Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
Circulating immune complexes in the sera of patients with confirmed histological diagnosis of carcinoma of the prostate, were found to interfere in the sensitized leukocyte's in vitro reactivity to prostate cancer associated antigen as evaluated by tube leukocyte adherence inhibition assay, thereby suggesting an inhibitory role of such serum factors in host's anti tumor cell mediated immune responses.
D000230:Adenocarcinoma / Q000276:immunology*; D000936:Antigen-Antibody Complex / Q000032:analysis / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology; D006801:Humans; D007957:Leukocyte Adherence Inhibition Test; D007962:Leukocytes / Q000276:immunology*; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology*
D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm